Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2025	Jun. 30, 2024
Current assets
Cash and cash equivalents	$ 226	$ 202
Receivables, net	597	695
Inventories, net	635	637
Prepaid expenses and other current assets	132	88
Total current assets	1,590	1,622
Property, plant and equipment, net of accumulated depreciation and amortization of $2,872 and $2,821, respectively	1,245	1,315
Operating lease right-of-use assets	349	360
Goodwill	1,222	1,228
Trademarks, net	501	538
Other intangible assets, net	68	143
Other assets	537	545
Total assets	5,512	5,751
Current liabilities
Notes and loans payable	54	4
Current operating lease liabilities	85	84
Accounts payable and accrued liabilities	2,016	1,486
Total current liabilities	2,155	1,574
Long-term debt	2,483	2,481
Long-term operating lease liabilities	322	334
Other liabilities	341	848
Deferred income taxes	21	22
Total liabilities	5,322	5,259
Commitments and contingencies
Stockholders’ equity
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of March 31, 2025 and June 30, 2024; and 123,251,595 and 124,201,807 shares outstanding as of March 31, 2025 and June 30, 2024, respectively	131	131
Additional paid-in capital	1,304	1,288
Retained earnings	99	250
Treasury stock, at cost: 7,489,866 and 6,539,654 shares as of March 31, 2025 and June 30, 2024, respectively	(1,331)	(1,186)
Accumulated other comprehensive net (loss) income	(176)	(155)
Total Clorox stockholders’ equity	27	328
Noncontrolling interests	163	164
Total stockholders’ equity	190	492
Total liabilities and stockholders’ equity	$ 5,512	$ 5,751